{
    "2021-02-01": [
        [
            {
                "time": "2023-02-01",
                "original_text": "格隆汇港股聚焦(02.01)︱富力地产1月总收入上升77%至113.6亿元；荣晖国际年度纯利预增1.7倍",
                "features": {
                    "keywords": [
                        "富力地产",
                        "总收入",
                        "上升77%",
                        "荣晖国际",
                        "年度纯利",
                        "预增1.7倍"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "房地产",
                        "国际投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-02-02",
                "original_text": "A股头条之上市公司（2.2）",
                "features": {
                    "keywords": [],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-02-02",
                "original_text": "上海医药(601607.SH)：治痛风药物别嘌醇片通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "上海医药",
                        "别嘌醇片",
                        "仿制药",
                        "一致性评价",
                        "治痛风"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-02-02",
                "original_text": "上海医药(02607)：痛风药别嘌醇片通过仿制药质量和疗效一致性评价",
                "features": {
                    "keywords": [
                        "上海医药",
                        "别嘌醇片",
                        "仿制药",
                        "质量和疗效一致性评价",
                        "痛风药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}